Antiviral Drug Resistance in Herpes Simplex Virus

  • Donald M. Coen
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 394)


Studies of drug resistance in herpesviruses have provided insights into the mechanisms of action of antiviral drugs, into the potential for drug resistance in the clinic and possible solutions, into virus enzyme structure-function relationships, and into mechanisms of basic viral processes ranging from gene expression to pathogenesis. Herpesvirus drug resistance has been reviewed extensively. 1–7 Therefore, rather than simply adding yet another factual review to this literature, I will instead mainly offer opinions on examples of each of the above kinds of insights and their potential clinical relevance. I will cite very few original papers, the reader can find ample citations to the original literature in the reviews listed above.


Thymidine Kinase Varicella Zoster Virus Antiviral Drug Trigeminal Ganglion Neuron Herpes Simplex VIruS 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Larder BA and Darby G Virus drug resistance: mechanisms and consequences Antiviral Res 1984 4,142.Google Scholar
  2. 2.
    Coen DM. General aspects of virus drug resistance with special reference to herpes simplex virus. J Antimicrob Chemother 1986: 18B: 1–10.PubMedCrossRefGoogle Scholar
  3. 3.
    Coen DM. The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy. Antiviral Res 1991; 15: 287–300.PubMedCrossRefGoogle Scholar
  4. 4.
    Chatis PA and Crumpacker CS Resistance of herpesviruses to antiviral drugs. Antimicrob Agents Chemother 1992. 36, 1589–1595.PubMedCrossRefGoogle Scholar
  5. 5.
    Coen DM. Drug resistance in herpesviruses. International Antiviral News 1993; 1: 98–99.Google Scholar
  6. 6.
    Field A.K. and Biron,K.K “The end of innocence” revisited: resistance of herpesviruses to antiviral drugs Clin Microb Revs 1994. 7, 1–13.Google Scholar
  7. 7.
    Coen DM. Acyclovir-resistant, pathogenic herpesviruses. Trends Microbiol 1994; 2, 481–485.PubMedCrossRefGoogle Scholar
  8. 7a.
    Martin JL, Brown CE, Matthews-Davis N, Reardon JE. Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob Agents Chemother. 1994; 38: 2743–2749.PubMedCrossRefGoogle Scholar
  9. 8.
    Reardon JE and Spector T. Herpes simplex virus type 1 DNA polymerase: mechanism of inhibition by acyclovir triphosphate. J Biol Chem 1989; 264: 7405–7411.PubMedGoogle Scholar
  10. 8a.
    Chiou HC, Kumura K, Hu A, Kerns KM, Coen DM. Penciclovir-resistance mutations in the herpes simplex virus DNA polymerase gene. Antiviral Chem Chemother. 1995; 6: 281–288.Google Scholar
  11. 9.
    Kost, R.G., Hill, E.L, Tigges M. et al. Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient N Engl J Med. 329, 1777–1782Google Scholar
  12. 10.
    Hwang CBC, Horsburgh B, Pelosi E, et al. A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc Natl Acad Sci USA 1994; 91: 5461–5465.PubMedCrossRefGoogle Scholar
  13. 11.
    Wang Y, Woodward S, Hall JD. Use of suppressor analysis to identify DNA polymerase mutations in herpes simplex virus which affect deoxynucleoside triphosphate substrate specificity. J Virol. 1992. 66, 1814–1816.PubMedGoogle Scholar
  14. 12.
    Kosz-Venenchak M, Coen DM, Knipe DM. Restricted expression of herpes simplex virus lytic genes during establishment of latent infection. J Virol. 1990; 64: 5396–5402.Google Scholar
  15. 13.
    Kosz-Vnenchak M, Jacobson J, Coen DM, et al. Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J Virol 1993; 67: 5383–5393.PubMedGoogle Scholar
  16. 14.
    Irmiere AF, Manos MM, Jacobson JG, et al. Effect of an amber mutation in the herpes simplex virus thymidine kinase gene on polypeptide synthesis and stability. Virology. 1989; 168: 210–220.PubMedCrossRefGoogle Scholar
  17. 15.
    Coen DM, Irmiere AF, Jacobson JG, et al. Low levels of herpes simplex virus thymidine-thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model. Virology. 1989; 168: 221–231.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Donald M. Coen

There are no affiliations available

Personalised recommendations